1月9日，美迪西涨5%，截至发稿，报71.16元/股，成交3.69亿元，换手率4.00%，总市值95.61亿元。 万家国证2000ETF（159628）成立日期2022年6月29日，最新规模12.86亿。今年以来收益4.84%，同类 排名1511/5509；近一年收益47.67%，同类排名1333/4198；成立以来收益41.01%。 万家国证2000ETF（159628）基金经理为杨坤。 截至发稿，杨坤累计任职时间6年80天，现任基金资产总规模138.68亿元，任职期间最佳基金回报 81.38%， 任职期间最差基金回报-32.3%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 资料显示，上海美迪西生物医药股份有限公司位于上海市浦东新区川沙新镇川大路585号，成立日期 2004年2月2日，上市日期2019年11月5日，公司主营业务涉及为医药企业和其他新药研发机构提供全方 位的新药研发服务。主营业务收入构成为：临床前研究50.34%，药物发现和药学研 ...

万家国证2000ETF（159628）基金经理为杨坤。 1月5日，美迪西涨5.27%，截至发稿，报59.37元/股，成交9569.76万元，换手率1.23%，总市值79.76亿 元。 截至发稿，杨坤累计任职时间6年76天，现任基金资产总规模138.68亿元，任职期间最佳基金回报 81.38%， 任职期间最差基金回报-32.3%。 资料显示，上海美迪西生物医药股份有限公司位于上海市浦东新区川沙新镇川大路585号，成立日期 2004年2月2日，上市日期2019年11月5日，公司主营业务涉及为医药企业和其他新药研发机构提供全方 位的新药研发服务。主营业务收入构成为：临床前研究50.34%，药物发现和药学研究49.64%，其他(补 充)0.01%。 从基金十大重仓股角度 数据显示，万家基金旗下1只基金重仓美迪西。万家国证2000ETF（159628）三季度持有股数9.95万 股，占基金净值比例为0.54%，位居第二大重仓股。根据测算，今日浮盈赚取约29.55万元。 万家国证2000ETF（159628）成立日期2022年6月29日，最新规模12.86亿。今年以来收益34.55%，同类 排名1391/4189；近一年收 ...

| 基金代码 | 基金简称 | 今日涨跌幅 | 今日成交额 | 较上一交易日增加 | 环比增幅 | | --- | --- | --- | --- | --- | --- | | 159628 | 万家国证2000ETF | -0.22% | 8799.04万元 | 3579.23万元 | 68.57% | | 159543 | 国证2000ETF基金 | -0.30% | 349.65万元 | 234.56万元 | 203.80% | | 159907 | 广发国证2000ETF | 0.10% | 1481.37万元 | 29.60万元 | 2.04% | | 159521 | 平安国证2000ETF | 0.00% | 83.35万元 | 19.32万元 | 30.17% | | 159505 | 博时国证2000ETF | -0.20% | 108.98万元 | 16.97万元 | 18.44% | 按成交金额环比增加看，国证2000ETF基金（159543）、万家国证2000ETF（159628）等今日成交额较 上一交易日分别增加203.80%、68.57%，增幅居前。 从市场表现看，截至收盘，国证 ...

统计显示，国证2000指数ETF今日合计成交额1.08亿元，环比上一交易日增加3879.67万元，环比增幅为 55.88%。 具体来看，万家国证2000ETF（159628）今日成交额8799.04万元，较上一交易日增加3579.23万元，环 比增幅为68.57%；国证2000ETF基金（159543）今日成交额349.65万元，较上一交易日增加234.56万 元，环比增幅为203.80%；广发国证2000ETF（159907）今日成交额1481.37万元，较上一交易日增加 29.60万元，环比增幅为2.04%。 按成交金额环比增加看，国证2000ETF基金（159543）、万家国证2000ETF（159628）等今日成交额较 上一交易日分别增加203.80%、68.57%，增幅居前。 国证2000指数ETF12月26日成交额变动 基金代码 基金简称 今日涨跌幅 今日成交额 较上一交易日增加 环比增幅 | 159628 | 万家国证2000ETF | -0.22% | 8799.04万元 | 3579.23万元 | 68.57% | | --- | --- | --- | --- | --- | --- | ...

Group 1 - The core viewpoint of the news is that Shanghai Medicilon Inc. has seen a stock price increase of 5.04%, reaching 59.77 CNY per share, with a total market capitalization of 8.03 billion CNY [1] - Medicilon was established on February 2, 2004, and went public on November 5, 2019, providing comprehensive new drug research and development services for pharmaceutical companies and other new drug research institutions [1] - The company's main business revenue composition includes 50.34% from preclinical research, 49.64% from drug discovery and pharmaceutical research, and 0.01% from other supplementary services [1] Group 2 - From the perspective of fund holdings, Wan Jia Fund has one fund heavily invested in Medicilon, specifically the Wan Jia National Index 2000 ETF, which held 99,500 shares, accounting for 0.54% of the fund's net value [2] - The Wan Jia National Index 2000 ETF was established on June 29, 2022, with a latest scale of 1.286 billion CNY and has achieved a year-to-date return of 26.92% [2] - The fund manager, Yang Kun, has a total asset scale of 13.868 billion CNY, with the best fund return during his tenure being 81.38% and the worst being -32.3% [2]

Core Insights - The total trading volume of the Guozheng 2000 Index ETF reached 165 million yuan today, an increase of 94.15 million yuan compared to the previous trading day, representing a growth rate of 132.74% [1] Trading Performance - Specifically, the Wanjia Guozheng 2000 ETF (159628) had a trading volume of 152 million yuan today, which is an increase of 108 million yuan from the previous trading day, reflecting a growth rate of 242.76% [1] - The Ping An Guozheng 2000 ETF (159521) recorded a trading volume of 1.2631 million yuan, up by 493,500 yuan from the previous day, with a growth rate of 64.12% [1] - The Guozheng 2000 Index (399303) rose by 0.35% by market close, while the average increase for related ETFs tracking the index was 0.06% [1] ETF Specifics - The top-performing ETFs in terms of trading volume increase were Wanjia Guozheng 2000 ETF (159628) and Ping An Guozheng 2000 ETF (159521), with increases of 242.76% and 64.12% respectively [1] - The worst-performing ETF was the Guozheng 2000 ETF Fund (159543), which decreased by 0.53% with a trading volume of 66,600 yuan, down by 269,230 yuan, representing a decline of 97.58% [1]

Market Overview - As of October 30, the total ETF margin balance in the two markets is 118.284 billion yuan, a decrease of 3.25 billion yuan from the previous trading day [1] - The financing balance is 110.05 billion yuan, down by 3.193 billion yuan, while the securities lending balance is 8.234 billion yuan, reduced by 57.9547 million yuan [1] - In the Shanghai market, the ETF margin balance is 82.462 billion yuan, a decrease of 2.532 billion yuan, with a financing balance of 75.209 billion yuan, down by 2.477 billion yuan [1] - In the Shenzhen market, the ETF margin balance is 35.822 billion yuan, a decrease of 719 million yuan, with a financing balance of 34.841 billion yuan, down by 715 million yuan [1] ETF Margin Balance - The top three ETFs by margin balance on October 30 are: - Huaan Yifu Gold ETF (8.181 billion yuan) - E Fund Gold ETF (5.722 billion yuan) - Huaxia Hang Seng (QDII-ETF) (4.116 billion yuan) [2] - The detailed top 10 ETFs by margin balance are provided in the table [2] ETF Financing Amount - The top three ETFs by financing amount on October 30 are: - Huatai-PB Southbound Hang Seng Technology Index (QDII-ETF) (2.015 billion yuan) - E Fund China Securities Hong Kong Investment Theme ETF (2.008 billion yuan) - Haifutong China Securities Short-term Bond ETF (1.703 billion yuan) [3] - The detailed top 10 ETFs by financing amount are provided in the table [4] ETF Net Financing Amount - The top three ETFs by net financing amount on October 30 are: - Huaan Growth Enterprise Board 50 ETF (114 million yuan) - E Fund CSI 300 Medical and Health ETF (62.307 million yuan) - Huabao CSI All-Index Securities Company ETF (49.924 million yuan) [5] - The detailed top 10 ETFs by net financing amount are provided in the table [6] ETF Securities Lending Amount - The top three ETFs by securities lending amount on October 30 are: - Huaxia Shanghai 50 ETF (32.5105 million yuan) - Huatai-PB CSI 300 ETF (22.6088 million yuan) - Southern CSI 500 ETF (18.3234 million yuan) [7] - The detailed top 10 ETFs by securities lending amount are provided in the table [8]

Core Viewpoint - Yichin Optoelectronics (600537.SH) reported a significant decline in institutional ownership in its Q3 2025 report, indicating potential shifts in investor confidence [1] Institutional Ownership - As of October 30, 2025, there is one institutional investor holding shares in Yichin Optoelectronics, with a total of 54.6962 million shares, representing 4.62% of the total share capital [1] - The institutional ownership percentage has decreased by 17.98 percentage points compared to the previous quarter [1] Public Fund Participation - In this reporting period, 26 public funds were disclosed, including notable funds such as the Shanghai Stock Exchange Composite Index ETF, Wanjiaguo Zheng 2000 ETF, and others [1]

Core Viewpoint - Chuangli Group (603012.SH) reported its Q3 2025 results, indicating a slight decrease in institutional investor holdings compared to the previous quarter [1] Institutional Holdings - As of October 30, 2025, three institutional investors disclosed holdings in Chuangli Group A-shares, totaling 142 million shares, which represents 21.96% of the company's total equity [1] - The institutional investors include Shanghai Jusheng Investment Co., Ltd., China Coal Machinery Group Co., Ltd., and Shanghai Yingshui Investment Management Co., Ltd. - Yingshui Rixin No. 4 Private Securities Investment Fund [1] - The total institutional holding percentage decreased by 0.09 percentage points compared to the previous quarter [1] Public Fund Holdings - In this reporting period, 29 public funds were not disclosed compared to the previous quarter, including Wanjiaguo Zheng 2000 ETF, CSI 2000, Guojin Quantitative Multi-Factor A, Guojin Quantitative Selected A, and Wanjiaguo Quantitative Tongshun A [1]

Core Viewpoint - Zhenlan Instrument (301303.SZ) reported its Q3 2025 results, highlighting a significant institutional investment presence with a total of 1.59 billion shares held by six institutional investors, representing 38.91% of the company's total equity [1] Institutional Investment - As of October 27, 2025, six institutional investors disclosed their holdings in Zhenlan Instrument, totaling 1.59 billion shares, which accounts for 38.91% of the total share capital [1] - The institutional holding percentage increased by 0.23 percentage points compared to the previous quarter [1] Public Fund Participation - In this reporting period, 47 public funds were disclosed, which were not reported in the previous quarter [1] - Notable public funds include Wanjiaguo Zheng 2000 ETF, Taiping Fengtai One-Year Open-End Bond Initiated Fund, and Huaxia Zhisheng New Star Stock A [1]